Passionfroot Raises $15M Series A to Expand B2B Creator Marketplace as AI Reshapes Marketing

Passionfroot, a German startup operating a marketplace connecting B2B creators with brands, has raised $15 million in a Series A round led by Insight Partners, with participation from existing backers Creandum, Supernode Global, and s16vc, bringing total funding to more than $21 million.

Insight Partners managing director Rebecca Liu-Doyle said the company is well positioned as AI-driven product launches push brands toward creator-led marketing for visibility and education, while creators increasingly build deep market expertise. Co-founder and CEO Jen Phan said AI is commoditizing software and flooding markets with new products, pushing B2B buyers toward creators on platforms like LinkedIn, Substack, and YouTube to discover tools.

With the new funding, Phan is relocating to New York as Passionfroot opens U.S. and São Paulo offices and expands beyond its current 15-person team. Phan said revenue grew 13-fold over the past year, with clients including ElevenLabs, Figma, Replit, Framer, and Gamma.

Since its 2024 fundraise, Passionfroot has launched an AI agent called Zest that helps brands build and monitor marketing campaigns and identify suitable creators using a proprietary data graph drawn from thousands of past campaigns. The company said it has paid creators at least $10 million over the last 18 months and is now developing tools to help clients track how campaigns influence AI-generated citations and brand visibility in AI-powered search results.

Featured image: Credit: Passionfroot

Need Deeper Intelligence on the AI Market?

AI Insider's Market Intelligence platform tracks funding rounds, competitive landscapes, and technology trends across the global AI ecosystem in real time. Get the data and insights your organization needs to make informed decisions.

Related Articles

gloved hands drawing vaccine from vial with syringe
Insilico Medicine Convenes an Open Consortium For Benchmark Quality in AI-Driven Drug Discovery

Insider Brief PRESS RELEASE — Insilico Medicine (“Insilico”; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the launch of the Open

Japan’s AI Strategy: From Society 5.0 to Generative AI

A policy analysis from August 2026 Japan was arguing about the shape of its AI future before most countries had a strategy at all. In

Data Centers
Top U.S. States for AI Data Centers And Infrastructure Growth

Insider Brief The best U.S. states for AI data center growth aren’t necessarily those with the most facilities, as access to electricity, water and room

Stay Updated with AI Insider

Get the latest AI funding news, market intelligence, and industry insights delivered to your inbox weekly.

$ 0 M

Seed round tracked

Gitar — Code Validation

Get the Weekly Briefing

Funding analysis, market intelligence, and industry trends delivered to your inbox every week.

Need bespoke intelligence?

Our team combines real-time data with decades of sector experience to guide your decisions.

Subscribe today for the latest news about the AI landscape